2017年度 Journal Club

Oncology

No.

日付

Title: Journal PMID

担当者

まとめ

21  14th/Mar

Atezolizumab versus docetaxel in patients with previously treated non-small-cell

lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Lancet 2017 27979383 児玉
20  28th/Feb

Edoxaban for the Treatment of Cancer- Associated Venous Thromboembolism

NEJM 2017 29231094 濵元 児玉
19  24th/Jan

Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia

Clinical Lung

Cancer 2017

29233611 桜田 児玉
18  20th/Dec

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer

NEJM 2017 29151359 井部 児玉
17  15th/Nov

Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Agent for Lung Cancer

JAMA Dermatology2017 28702789 福田 児玉 
16   8th/Nov

Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive

non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial

Lancet 2017 28958502

薬学

学生

児玉
15  11th/Oct

Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line

Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung Cancers

JTO 2017 28751244 濵元 濵元
14  27th/Sep

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

NEJM 2017 28885881 薬学 濵元
13 20th/Sep

A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R

JTO 2017 28576746 児玉 児玉
12 13th/Sep

Depression, inflammation, and epidermal growth factor receptor (EGFR) status in metastatic non-small cell lung cancer: A pilot study

J Psychosomatic

Research 2017

28712427 鬼塚 児玉
11  6th/Sep

Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

Lancet Oncology 2016 27283860 井部 児玉
10 26th/July

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

NEJM 2017 28636851 濵元 児玉
9 19th/July

Incidence of pneumonitis with use of PD-1 and PD-L1 inhibitors in non-small cell lung cancer:

A Systematic Review and Meta-analysis of trials

Chest 2017 28499515 福田 児玉
8  5th/July

Multicenter, Phase III, Randomized, Double-Blind, Placebo- Controlled Trial of Pravastatin

Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)

JCO 2017 28240967 薬学 児玉
7 28th/June

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment

of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Lancet Oncology 2017   児玉 児玉
6 21st/June

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

NEJM 2017   井部 児玉
5 14th/June

Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

JCO 2017   濵元 児玉
4 31st/May

Randomised phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group

    田代 児玉
3 10th/May

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

JCO 2017   濵元 児玉
2 26th/April

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

Lancet Oncology 2017   児玉 児玉
5th/April

Management of Brain Metastases in Tyrosine Kinase Inhibitor–Na ̈ıve Epidermal Growth Factor

Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi- Institutional Analysis 

JCO 2017;35 1070-1077   濵元 児玉

COPD&Asthma


Infection


DM

No.

日付

Title: Journal PMID

担当者

まとめ

 1 31st/Jan Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis   28596247  大越  児玉

Supportive Care

No.

日付

Title: Journal PMID

担当者

まとめ

 2  7th/June

A phase II randomized double-blind placebo-controlled study of 6-gingerol as ananti

-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy

 Medical Oncology 2017 28349496    児玉
 1 19th/April

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

 NEJM 2017    井部  児玉

Any issues